Therapy with High Dose Recombinant Alpha 2 Interferon (IFN-alpha 2) Produces a Depression in Natural Killer Cell Cytotoxicity

Overview

Journal Br J Cancer

Specialty Oncology

Date 1984 Aug 1

PMID 6466539

Citations 2

Authors

B Tank

R L Marquet

W Weimar

D L Westbroek

Affiliations

Soon will be listed here.

Citing Articles

A phase I toxicity study of human rDNA interferon in patients with solid tumours.

Wagstaff J, Chadwick G, Howell A, Thatcher N, Scarffe J, Crowther D Cancer Chemother Pharmacol. 1984; 13(2):100-5.

PMID: 6467493 DOI: 10.1007/BF00257123.

Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A).

Eggermont A, Weimar W, Tank B, Marquet R, Lameris J, Westbroek D Cancer Immunol Immunother. 1986; 21(1):81-4.

PMID: 3632919 PMC: 11038461. DOI: 10.1007/BF00199382.

References

Lotzova E, Savary C, Gutterman J, Hersh E . Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha. Cancer Res. 1982; 42(6):2480-8. View

Maluish A, Ortaldo J, Conlon J, Sherwin S, Leavitt R, Strong D . Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol. 1983; 131(1):503-7. View

Ortaldo J, Bonnard G, Herberman R . Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol. 1977; 119(4):1351-7. View

Oehler J, Herberman R . Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid. Int J Cancer. 1978; 21(2):221-9. DOI: 10.1002/ijc.2910210214. View

SKURKOVICH S, SKORIKOVA A, Eremkina E . Enhancement by interferon of lymphocyte cytotoxicity in normal individuals to cells of human lymphoblastoid lines. J Immunol. 1978; 121(3):1173-6. View

Staehelin T, Hobbs D, Kung H, Lai C, Pestka S . Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J Biol Chem. 1981; 256(18):9750-4. View

Huddlestone J, MERIGAN Jr T, Oldstone M . Induction and kinetics of natural killer cells in humans following interferon therapy. Nature. 1979; 282(5737):417-9. DOI: 10.1038/282417a0. View

GRESSER I, De Maeyer-Guignard J, Tovey M, De Maeyer E . Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci U S A. 1979; 76(10):5308-12. PMC: 413131. DOI: 10.1073/pnas.76.10.5308. View

Saksela E, Timonen T, Cantell K . Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells. Scand J Immunol. 1979; 10(3):257-66. DOI: 10.1111/j.1365-3083.1979.tb01348.x. View

10.

Herberman R, Ortaldo J, Bonnard G . Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature. 1979; 277(5693):221-3. DOI: 10.1038/277221a0. View

11.

EINHORN S, Blomgren H, Strander H . Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer. 1980; 26(4):419-28. DOI: 10.1002/ijc.2910260406. View

12.

EINHORN S, Blomgren H, Strander H . Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer. 1978; 22(4):405-12. DOI: 10.1002/ijc.2910220407. View